102¦~4¤ë¸¹ ¹D ªk ªk °T (252)

DEEP & FAR

 

 

³Ì°ªªk°|¥H¤£¥i±M§Q¤§¦ÛµMªk«h

®Ö»é¤F­Ó¤H¤ÆªºÃĪ«±M§Q½Ð¨D¶µ (¤@)

by Sullivan & Worcester LLP Intellectual Property Advisory

 

¼ï¾i·½ ±M§Q¤G²Õ°Æ¥D¥ô

¡E¤¤¥¿²z¤u¾Ç°|¹q¾÷¨t

¡E¬Fªv¤j¾Ç¥ø·~ºÞ²zºÓ¤h

¡E¬ü°ê±K¦è®Ú¤j¾Ç¤u·~¤Î§@·~¤uµ{ºÓ¤h/³Õ¤h­Ô¿ï¤H

 

 

¥h¦~¤T¤ë¡A³Ì°ªªk°|¥H¯Ê¥F¥i±M§Q¤§¼ÐªºµL²§Ä³¦a§P©w¤F¨â­Ó±M§QµL®Ä¡C¦bMayo Collaborative Services¹ï Prometheus Laboratories Inc.ªº­Ó®×¤¤¡Aªk°|§P©wPrometheusªº±M§Q½Ð¨D¶µ¤£«ê·í¦a¶D¨D¦ÛµMªk«h¡C

¸Óµ¥±M§Q¬O¶D¨D¨M©w¤@ªvÀø¨Ò¦p§J¶©¤ó¯g(Crohn¡¦s disease)¤§¦ÛÅé§K¬Ì¯e¯f¤§Ãľ¯(thiopurine)¾A·í¾¯¶qªº¤èªk¡C¸Óµ¥±M§Qªº½Ð¨D¶µ¤@¯ë©Ê¦a±Ô­z¤U¦C¨BÆJ¡G(1)§ë°e¤@Ãľ¯¤©¤@¯f±w¡F¥H¤Î(2)¨M©w¦b¸Ó¯f±wÅ餺¸ÓÃľ¯¥NÁª«¤§¤ô·Ç¡C¸Ó½Ð¨D¶µ¥ç±Ô­z¸ÓÃĪ«¥NÁª«ªº¤ô·Ç«ü¥Ü¬O§_­n¼W¥[©Î­°§C¸ÓÃĪ«¤§¾¯¶q¡A¥H½T«O¸ÓÃľ¯¦s¦b¤@¨Ï¤§¦³®Äªº¾A¶q¡A¦ý¥ç¬O¤@¤p¨ìÁקK¶Ë¤Î¸Ó¯f±w¤§¾¯¶q¡Cªk°|§P©w¦bÃĪ«¥NÁª«¤ô·Ç»PÃĪ«¦³®Ä©Ê©Î¶Ë®`µ¥¤§¥i¯à©Ê¶¡ªºÃö«Y¬O¤@¤£¥i±M§Qªº¦ÛµMªk«h¡C

³Ì°ªªk°|«Ü¦­¥H«e§Y§P©w¡G¡u¦ÛµMªk«h¡B¦ÛµM²{¶H¥H¤Î©â¶HÆ[©À¡v¬O¤£¥i±M§Qªº¡C¦]»{ª¾¦b¬YºØ¤ô·Ç¤W¡A©Ò¦³ªºµo©úÅé²{©Î¥õ¿à¦ÛµMªk«h¡B¦ÛµM²{¶H¥H¤Î©â¶HÆ[©À¡A¸Óªk°|«e´¿¸ÑÄÀ¡u¤@­Ó¹ï¤@¤wª¾µ²ºc©Îµ{§Ç¤§¦ÛµMªk«h©Î¼Æ¾Ç¤½¦¡¤§À³¥Î¡A¥i¯à¬O«Ü­È±o±M§Q«OÅ@ªº¡v¡C¦b¥Ø«eªº­Ó®×¤¤¡A¸Óªk°|°µ¥Xµ²½×¡A¸Óµ¥½Ð¨D¶µ©Ò«Øijªº¶È¥u¸û¤@¦ÛµMªk«h¤§À³¥Î¦h¤@¨Ç¡C¸Óªk°|«ÅºÙ¸Óµ¥©Ò¥D±i¤§¨BÆJ¡u¶È§iª¾Âå¥Í»`¶°¸ê®Æ¡A±q¨ä¤¤¥L­Ì¥i¥H«ö·Ó¬ÛÃö©Ê°µ¥X±ÀÂ_¡v¡C¸Óªk°|¸ß°Ý¥H¤Î¦^ÂСu¬°¨Ï¸Ó¨Æ¶µ§ó©ú½T¡A½Ð°Ý¸Óµ¥±M§Q½Ð¨D¶µ¬O§_¼W¥[¨¬°÷ªº¬ÛÃö©Ê±Ô­z¡A¦Ó¨Ï¨ä©Ò±Ô­z¤§µ{§Ç°÷¸ê®æ¦¨¬°¹B¥Î¦ÛµMªk«h¦Ó¾A¦X±M§Q¤§µ{§Ç©O¡H¬Û«Hµª®×¬O§_©wªº¡v¡C¸Ó·N¨£¥ç«Øij¤F¹ï¸Óµ¥½Ð¨D¶µ¤§½dÃ¥ªºÃö¤Á¡A«ÅºÙ­ã³\³o¨Ç½Ð¨D¶µ±N¤£¾A·í¦a¤¹³\¦ÛµMªk«hªº¼sªxªº¥ý¦ûÅv¡C